279 related articles for article (PubMed ID: 22206670)
1. Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo.
Lei X; Lv X; Liu M; Yang Z; Ji M; Guo X; Dong W
Biochem Biophys Res Commun; 2012 Jan; 417(2):864-8. PubMed ID: 22206670
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
3. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3.
Park JE; Kim DH; Ha E; Choi SM; Choi JS; Chun KS; Joo SH
Chem Biol Interact; 2019 Oct; 312():108799. PubMed ID: 31433961
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
Mu GG; Zhang LL; Li HY; Liao Y; Yu HG
Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
[TBL] [Abstract][Full Text] [Related]
8. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
[TBL] [Abstract][Full Text] [Related]
9. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.
Hou G; Yuan X; Li Y; Hou G; Liu X
Invest New Drugs; 2020 Apr; 38(2):329-339. PubMed ID: 31102118
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy.
Chu SC; Hsieh YS; Yu CC; Lai YY; Chen PN
PLoS One; 2014; 9(7):e101579. PubMed ID: 25000169
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.
Kensara OA; El-Shemi AG; Mohamed AM; Refaat B; Idris S; Ahmad J
Drug Des Devel Ther; 2016; 10():2239-53. PubMed ID: 27468227
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells.
Samarghandian S; Azimi-Nezhad M; Farkhondeh T
J Cell Physiol; 2019 Jul; 234(7):10421-10431. PubMed ID: 30387147
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines.
Ichwan SJ; Al-Ani IM; Bilal HG; Suriyah WH; Taher M; Ikeda MA
Chin J Physiol; 2014 Oct; 57(5):249-55. PubMed ID: 25241984
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.
Chae IG; Song NY; Kim DH; Lee MY; Park JM; Chun KS
Food Chem Toxicol; 2020 May; 139():111253. PubMed ID: 32165235
[TBL] [Abstract][Full Text] [Related]
15. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
16. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
Kim HM; Kim SA; Park SB; Cho JH; Song SY
Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
[TBL] [Abstract][Full Text] [Related]
18. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS.
Woo CC; Hsu A; Kumar AP; Sethi G; Tan KH
PLoS One; 2013; 8(10):e75356. PubMed ID: 24098377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
